சீனா புராண ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா புராண ஹோல்டிங்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா புராண ஹோல்டிங்ஸ் Today - Breaking & Trending Today

Temasek, Lake Bleu lead $156m Series C round for Chinese vaccine developer RecBio

Temasek, Lake Bleu lead $156m Series C round for Chinese vaccine developer RecBio
Photo by Diana Polekhina on Unsplash
June 14, 2021
Rec-Biotechnology (RecBio), a Chinese developer of genetically engineered vaccines, has secured about 1 billion yuan ($156.3 million) in a Series C round of financing jointly led by Singapore state investor Temasek Holdings and Hong Kong-based asset manager Lake Bleu Capital.
Chinese asset management company E Fund Management and private equity firm Boyu Capital participated in the round, alongside existing shareholders such as Legend Capital, an investment unit of China’s Legend Holdings, healthcare fund LYFE Capital, and Sequoia Capital China.
The new financing came about seven months after it raked in over 1.5 billion yuan in a Series B round in November 2020. Its Series A round, which was closed in January 2019, collected 500 million yuan from investors including Chinese venture capital firm Oriental Fortune Capital, and CR ....

Abzymo Biosciences , China Legend Holdings , E Fund Management , Temasek Holdings , Hong Kong Based , Lake Bleu , Boyu Capital , Legend Capital , Legend Holdings , Sequoia Capital , Oriental Fortune Capital , Taizhou City , Jiangsu Province , Jiangsu Rec Biotechnology , Beijing Abzymo , Lake Bleu Capital , சீனா புராண ஹோல்டிங்ஸ் , ஏ நிதி மேலாண்மை , தேமாஸேக் ஹோல்டிங்ஸ் , ஹாங் காங் அடிப்படையிலானது , ஏரி ப்ளூ , புராண மூலதனம் , புராண ஹோல்டிங்ஸ் , சீக்வோயா மூலதனம் , ஓரியெஂடல் அதிர்ஷ்டம் மூலதனம் , தைழௌ நகரம் ,

China's Legend Capital closes healthcare continuation fund after $270m secondary deal

China’s Legend Capital closes healthcare continuation fund after $270m secondary deal
Photo by Hush Naidoo on Unsplash
May 20, 2021
Legend Capital, a subsidiary of China’s Legend Holdings, announced that it has closed its healthcare continuation fund LC Healthcare Continued Fund I having raised $270 million from a secondary transaction.
A continuation fund is a vehicle that takes on the portfolio assets of a vintage fund that is nearing the end of its lifespan. LPs are given the option to cash out, or to stay invested by recommitting to the new vehicle.
The latest secondary transaction involved assets from Legend Capital’s two older vehicles, the VC firm said in a statement. The latest fundraising was “co-led by accounts managed by Hamilton Lane and Coller Capital, with participation from other institutional investors”. ....

Mingchen Xia , Gibson Dunn , Bloks Group , Tlc Fund , Legend Holdings , China Legend Holdings , Lc Healthcare Continued Fund , Horizon Health , Legend Capital , Hamilton Lane , Coller Capital , United Kingdom Based , Access Medical Systems , Hong Kong Listed , New Horizon Health , Asia Investments Mingchen Xia , கிப்சன் டன் , எல்சி நிதி , புராண ஹோல்டிங்ஸ் , சீனா புராண ஹோல்டிங்ஸ் , அடிவானம் ஆரோக்கியம் , புராண மூலதனம் , ஹாமில்டன் சந்து , காலர் மூலதனம் , ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது , நுழைவு மருத்துவ அமைப்புகள் ,